Abacus Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
Abacus Wealth Partners's AMGN Position: Q2 2026 in Review
Abacus Wealth Partners reduced its Amgen (AMGN) stake by 47% in Q2 2026, selling an estimated $342K and leaving 1,112 shares worth $403K. The position accounts for 0.04% of the portfolio, ranked #188.
Abacus Wealth Partners first reported a position in AMGN in Q4 2020 and has held it in 13 quarters since. The position peaked at $743K in Q1 2026. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Abacus Wealth Partners held 1,112 shares of Amgen worth $403K as of Q2 2026.
- Abacus Wealth Partners sold 1,000 Amgen shares in Q2 2026, an estimated $342K.
- Amgen made up 0.04% of Abacus Wealth Partners's portfolio in Q2 2026, its #188 holding.
- Abacus Wealth Partners first reported a position in Amgen in Q4 2020 and has held it in 13 quarters since.
- Abacus Wealth Partners's Amgen position peaked at $743K in Q1 2026.
- 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Abacus Wealth Partners's 13F filing for Q2 2026, filed 22 Jul 2026.